Literature DB >> 30025081

A Cross-Sectional and Longitudinal Study of Retinal Sensitivity in RPE65-Associated Leber Congenital Amaurosis.

Neruban Kumaran1,2, Gary S Rubin1,2, Angelos Kalitzeos1,2, Kaoru Fujinami1,2,3,4, James W B Bainbridge1,2, Richard G Weleber5, Michel Michaelides1,2.   

Abstract

Purpose: RPE65-associated Leber congenital amaurosis (RPE65-LCA) is an early-onset severe retinal dystrophy associated with progressive visual field loss. Phase I/II and III gene therapy trials have identified improved retinal sensitivity but little is known about the natural history of retinal sensitivity in RPE65-LCA.
Methods: A total of 19 subjects (aged 9 to 23 years) undertook monocular full-field static perimetry of which 13 subjects were monitored longitudinally. Retinal sensitivity was measured as mean sensitivity (MS) and volumetrically quantified (in decibel-steradian) using visual field modeling and analysis software for the total (VTOT), central 30° (V30) and central 15° (V15) visual field. Correlation was evaluated between retinal sensitivity and age, best-corrected visual acuity (BCVA), contrast sensitivity, vision-related quality of life, and genotype. Test-retest reliability was also investigated.
Results: V30 was identified to have a strong, weak, and moderate correlation with age, BCVA and contrast sensitivity respectively. Furthermore, V30 was identified as having a weak linear relationship with the mobility and independence domains of the vision-related quality of life questionnaire. Longitudinal analysis demonstrated a slow loss of retinal sensitivity in this cohort. Subjects with at least one RPE65 nonsense variant appeared to show greater progressive loss of retinal sensitivity in the second decade of life than those without. Conclusions: Volumetric assessment of central 30° visual field sensitivity, V30, is a useful independent measure of retinal function and, in our data, represented the best metric to monitor deterioration of retinal sensitivity in RPE65-LCA. Furthermore, functional correlation with genotype may enable more informed prognostic counseling. (ClinicalTrials.gov number, NCT02714816.)

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30025081      PMCID: PMC6040235          DOI: 10.1167/iovs.18-23873

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

1.  Effect of instructions on conventional automated perimetry.

Authors:  K E Kutzko; C F Brito; M Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

2.  Early-onset severe rod-cone dystrophy in young children with RPE65 mutations.

Authors:  B Lorenz; P Gyürüs; M Preising; D Bremser; S Gu; M Andrassi; C Gerth; A Gal
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

3.  Reliability: on the reproducibility of assessment data.

Authors:  Steven M Downing
Journal:  Med Educ       Date:  2004-09       Impact factor: 6.251

4.  Comparison between semiautomated kinetic perimetry and conventional Goldmann manual kinetic perimetry in advanced visual field loss.

Authors:  Katarzyna Nowomiejska; Reinhard Vonthein; Jens Paetzold; Zbigniew Zagorski; Randy Kardon; Ulrich Schiefer
Journal:  Ophthalmology       Date:  2005-08       Impact factor: 12.079

5.  Automated perimetry detects visual field loss before manual Goldmann perimetry.

Authors:  J Katz; J M Tielsch; H A Quigley; A Sommer
Journal:  Ophthalmology       Date:  1995-01       Impact factor: 12.079

6.  The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis.

Authors:  Ecosse L Lamoureux; Julie F Pallant; Konrad Pesudovs; Gwyn Rees; Jennifer B Hassell; Jill E Keeffe
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

7.  Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST).

Authors:  M Klein; D G Birch
Journal:  Doc Ophthalmol       Date:  2009-11-03       Impact factor: 2.379

8.  Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations.

Authors:  Samuel G Jacobson; Tomas S Aleman; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Elizabeth A M Windsor; Sharon B Schwartz; Elise Heon; Edwin M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-30       Impact factor: 4.799

9.  VFMA: Topographic Analysis of Sensitivity Data From Full-Field Static Perimetry.

Authors:  Richard G Weleber; Travis B Smith; Dawn Peters; Elvira N Chegarnov; Scott P Gillespie; Peter J Francis; Stuart K Gardiner; Jens Paetzold; Janko Dietzsch; Ulrich Schiefer; Chris A Johnson
Journal:  Transl Vis Sci Technol       Date:  2015-04-28       Impact factor: 3.283

10.  Predicting the pathogenicity of RPE65 mutations.

Authors:  A R Philp; M Jin; S Li; E I Schindler; A Iannaccone; B L Lam; R G Weleber; G A Fishman; S G Jacobson; R F Mullins; Gabriel H Travis; Edwin M Stone
Journal:  Hum Mutat       Date:  2009-08       Impact factor: 4.878

View more
  9 in total

Review 1.  Leber's Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations.

Authors:  Chu-Hsuan Huang; Chung-May Yang; Chang-Hao Yang; Yu-Chih Hou; Ta-Ching Chen
Journal:  Genes (Basel)       Date:  2021-08-19       Impact factor: 4.096

2.  Characterizing Visual Fields in RPGR Related Retinitis Pigmentosa Using Octopus Static-Automated Perimetry.

Authors:  Thomas M W Buckley; Amandeep Singh Josan; Laura J Taylor; Jasleen K Jolly; Jasmina Cehajic-Kapetanovic; Robert E MacLaren
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

Review 3.  Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.

Authors:  Albert M Maguire; Jean Bennett; Elena M Aleman; Bart P Leroy; Tomas S Aleman
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

4.  Retinal Structure in RPE65-Associated Retinal Dystrophy.

Authors:  Neruban Kumaran; Michalis Georgiou; James W B Bainbridge; Mette Bertelsen; Michael Larsen; Fiona Blanco-Kelly; Carmen Ayuso; Hoai Viet Tran; Francis L Munier; Angelos Kalitzeos; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-04-09       Impact factor: 4.799

5.  Novel gene variants in Polish patients with Leber congenital amaurosis (LCA).

Authors:  Anna Skorczyk-Werner; Zuzanna Niedziela; Marcin Stopa; Maciej Robert Krawczyński
Journal:  Orphanet J Rare Dis       Date:  2020-12-11       Impact factor: 4.123

6.  RPE65-Associated Retinopathies in the Italian Population: A Longitudinal Natural History Study.

Authors:  Francesco Testa; Vittoria Murro; Sabrina Signorini; Leonardo Colombo; Giancarlo Iarossi; Francesco Parmeggiani; Benedetto Falsini; Anna Paola Salvetti; Raffaella Brunetti-Pierri; Giorgia Aprile; Chiara Bertone; Agnese Suppiej; Francesco Romano; Marianthi Karali; Simone Donati; Paolo Melillo; Andrea Sodi; Luciano Quaranta; Luca Rossetti; Luca Buzzonetti; Marzio Chizzolini; Stanislao Rizzo; Giovanni Staurenghi; Sandro Banfi; Claudio Azzolini; Francesca Simonelli
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-02-01       Impact factor: 4.799

7.  Validation of a Vision-Guided Mobility Assessment for RPE65-Associated Retinal Dystrophy.

Authors:  Neruban Kumaran; Robin R Ali; Nick A Tyler; James W B Bainbridge; Michel Michaelides; Gary S Rubin
Journal:  Transl Vis Sci Technol       Date:  2020-09-03       Impact factor: 3.283

8.  Long-Term Investigation of Retinal Function in Patients with Achromatopsia.

Authors:  Michalis Georgiou; Navjit Singh; Thomas Kane; Serena Zaman; Nashila Hirji; Jonathan Aboshiha; Neruban Kumaran; Angelos Kalitzeos; Joseph Carroll; Richard G Weleber; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.925

9.  Characterization of Retinal Function Using Microperimetry-Derived Metrics in Both Adults and Children With RPGR-Associated Retinopathy.

Authors:  Evgenia Anikina; Michalis Georgiou; James Tee; Andrew R Webster; Richard G Weleber; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2021-07-22       Impact factor: 5.258

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.